A trial of an investigational injectable medicine for prurigo nodularis
You may be able to participate in the study if you
- Are 18 years or older at the time of informed consent.
- Have a physician’s decision to be treated with dupilumab for prurigo nodularis made prior to and independently of the patient’s participation in the study
- Must not have a contraindication to dupilumab according to the country-specific prescribing information label.
- Must not have any condition that may interfere with the patient’s ability to participate in the
study, or comorbidities that can predictably prevent the patient from completing the schedule of visits and assessments.
Trial Application Form
- 105-5 Quarry Ridge Rd. Barrie, On, L4M 7G1